The latest research news in genetics and genomics.
New male pattern baldness candidates turned up in an analysis of more than 70,000 individuals, including UK Biobank participants profiled for a prior baldness GWAS.
The company said in April that it planned to launch a test this year but has since decided to take more time to better assess the clinical need and market.
Since 2015, the Regeneron Genetics Center has sequenced 250,000 exomes from phenotyped individuals, identifying "human knockouts" and other large-effect mutations.
The work demonstrates the ability of mass spectrometry to profile protein complexes in their native states in great detail and with relatively high throughput.
A null mutation in the SERPINE1 gene was associated with longer telomeres and increased longevity among carriers, a new study found.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
This online seminar, part of the 2017 ABRF Webinar Series, will help lab directors and administrators gain a 101 understanding of file naming, data storage, and data security.